Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
暂无分享,去创建一个
R. Klein | B. Klein | G. King | D. Bowden | B. Freedman | E. Barrett | S. Craft | A. Vinik | M. Khamaisi | Zhenqi Liu | C. Casellini | T. Hughes | Carolina M Casellini | R. Klein
[1] Fitriani Fitriani,et al. THE PREVALENCE OF DIABETIC RETINOPATHY , 2018 .
[2] A. Izenberg,et al. Diabetic Neuropathies , 2015, Seminars in Neurology.
[3] P. Arner,et al. Fatty Acids, Obesity and Insulin Resistance , 2015, Obesity Facts.
[4] C. Sudlow,et al. Enlarged perivascular spaces and cerebral small vessel disease , 2013, International journal of stroke : official journal of the International Stroke Society.
[5] I. Akgun. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection: a Meta-analysis , 2015 .
[6] S. Kritchevsky,et al. Sensory and Motor Peripheral Nerve Function and Incident Mobility Disability , 2014, Journal of the American Geriatrics Society.
[7] David C. Anderson,et al. Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortical strokes trial. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[8] T. Motawi,et al. Alterations in circulating angiogenic and anti‐angiogenic factors in type 2 diabetic patients with neuropathy , 2014, Cell biochemistry and function.
[9] J. Kielstein,et al. Glucose levels and risk of dementia. , 2013, The New England journal of medicine.
[10] B. Bravenboer,et al. Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms. , 2013, European journal of pharmacology.
[11] Larson J. Hogstrom,et al. The structure of the cerebral cortex across adult life: age-related patterns of surface area, thickness, and gyrification. , 2013, Cerebral cortex.
[12] Ling Xia,et al. Inhibition of Src Kinase Blocks High Glucose–Induced EGFR Transactivation and Collagen Synthesis in Mesangial Cells and Prevents Diabetic Nephropathy in Mice , 2013, Diabetes.
[13] C. DeCarli,et al. Amylin deposition in the brain: A second amyloid in Alzheimer disease? , 2013, Annals of Neurology.
[14] L. Ferrucci,et al. Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging , 2013, Neurobiology of Aging.
[15] W. Mali,et al. Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study , 2013, Journal of the Neurological Sciences.
[16] R. Sacco,et al. Perivascular Spaces Are Associated with Atherosclerosis: An Insight from the Northern Manhattan Study , 2013, American Journal of Neuroradiology.
[17] L. Ferrucci,et al. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. , 2013, JAMA neurology.
[18] H. Abboud,et al. The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo. , 2013, American journal of physiology. Renal physiology.
[19] E. Schuchman,et al. Synergistic vasculogenic effects of AMD3100 and stromal-cell-derived factor-1α in vasa nervorum of the sciatic nerve of mice with diabetic peripheral neuropathy , 2013, Cell and Tissue Research.
[20] Xin Lv,et al. CHOP/ORP150 Ratio in Endoplasmic Reticulum Stress: A New Mechanism for Diabetic Peripheral Neuropathy , 2013, Cellular Physiology and Biochemistry.
[21] C. Annweiler,et al. Blood pressure levels and brain volume reduction: a systematic review and meta-analysis , 2013, Journal of hypertension.
[22] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[23] J. Muller-Delp. The Coronary Microcirculation in Health and Disease , 2013 .
[24] Á. Valverde,et al. Insulin directly stimulates VEGF-A production in the glomerular podocyte. , 2013, American journal of physiology. Renal physiology.
[25] G. Sobue,et al. Association of Chronic Kidney Disease and Cerebral Small Vessel Disease with Cognitive Impairment in Elderly Patients with Type 2 Diabetes , 2013, Dementia and Geriatric Cognitive Disorders Extra.
[26] Aifeng Zhang,et al. White Matter Tract Integrity of Anterior Limb of Internal Capsule in Major Depression and Type 2 Diabetes , 2013, Neuropsychopharmacology.
[27] M. White,et al. Serine Phosphorylation Sites on IRS2 Activated by Angiotensin II and Protein Kinase C To Induce Selective Insulin Resistance in Endothelial Cells , 2013, Molecular and Cellular Biology.
[28] Benjamin J. Keller,et al. From Single Nucleotide Polymorphism to Transcriptional Mechanism , 2013, Diabetes.
[29] Yun Shi,et al. Elevated Protein Carbonylation, and Misfolding in Sciatic Nerve from db/db and Sod1−/− Mice: Plausible Link between Oxidative Stress and Demyelination , 2013, PloS one.
[30] M. Weiner,et al. White matter hyperintensities: use of aortic arch pulse wave velocity to predict volume independent of other cardiovascular risk factors. , 2013, Radiology.
[31] W. Sheu,et al. Advanced glycation end product Nε‐carboxymethyllysine induces endothelial cell injury: the involvement of SHP‐1‐regulated VEGFR‐2 dephosphorylation , 2013, The Journal of pathology.
[32] Wiro J Niessen,et al. High Blood Pressure and Cerebral White Matter Lesion Progression in the General Population , 2013, Hypertension.
[33] A. Vinik,et al. Neurovascular Function and Sudorimetry in Health and Disease , 2013, Current Diabetes Reports.
[34] E. Feener,et al. Role of plasma kallikrein in diabetes and metabolism , 2013, Thrombosis and Haemostasis.
[35] A. Ghosh,et al. Molecular basis of organ fibrosis: Potential therapeutic approaches , 2013, Experimental biology and medicine.
[36] G. Alexander,et al. Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions , 2013, Neurology.
[37] H. Liao,et al. VEGF -634G>C polymorphism and diabetic retinopathy risk: a meta-analysis. , 2013, Gene.
[38] C. Jack,et al. Mapping creatinine- and cystatin C-related white matter brain deficits in the elderly , 2013, Neurobiology of Aging.
[39] Y. You,et al. Role of Nox2 in diabetic kidney disease. , 2013, American journal of physiology. Renal physiology.
[40] S. Rich,et al. Family-Based Association Analysis Confirms the Role of the Chromosome 9q21.32 Locus in the Susceptibility of Diabetic Nephropathy , 2013, PloS one.
[41] Peter R Luijten,et al. In Vivo Detection of Cerebral Cortical Microinfarcts with High-Resolution 7T MRI , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[42] J. McMurray,et al. Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON) , 2013, American Journal of Nephrology.
[43] Benjamin J. Keller,et al. From SNP to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy , 2013 .
[44] K. Maddipati,et al. 12/15-Lipoxygenase-Derived Lipid Metabolites Induce Retinal Endothelial Cell Barrier Dysfunction: Contribution of NADPH Oxidase , 2013, PloS one.
[45] Kristine Yaffe,et al. Macro- and Microstructural Magnetic Resonance Imaging Indices Associated With Diabetes Among Community-Dwelling Older Adults , 2013, Diabetes Care.
[46] O. Abe,et al. White Matter Alteration in Metabolic Syndrome , 2013, Diabetes Care.
[47] T. Hansen,et al. What Is the Contribution of Two Genetic Variants Regulating VEGF Levels to Type 2 Diabetes Risk and to Microvascular Complications? , 2013, PloS one.
[48] J. Rosenstock,et al. Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. , 2013, The American journal of medicine.
[49] L. Schmetterer,et al. Neurovascular dysfunction precedes neural dysfunction in the retina of patients with type 1 diabetes. , 2013, Investigative ophthalmology & visual science.
[50] D. Wasserman,et al. Muscle-Specific Vascular Endothelial Growth Factor Deletion Induces Muscle Capillary Rarefaction Creating Muscle Insulin Resistance , 2013, Diabetes.
[51] Sterling C. Johnson,et al. Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults , 2013, Diabetes Care.
[52] Lina Zhao,et al. Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment. , 2013, American journal of physiology. Endocrinology and metabolism.
[53] G. King,et al. Vascular complications of diabetes: mechanisms of injury and protective factors. , 2013, Cell metabolism.
[54] H. Arai,et al. Brain accumulation of amyloid β protein visualized by positron emission tomography and BF‐227 in Alzheimer's disease patients with or without diabetes mellitus , 2013, Geriatrics & gerontology international.
[55] N. Vaziri,et al. Targeting the Transcription Factor Nrf2 to Ameliorate Oxidative Stress and Inflammation in Chronic Kidney Disease , 2012, Kidney international.
[56] S. Craft,et al. Insulin and Alzheimer's disease: untangling the web. , 2012, Journal of Alzheimer's disease : JAD.
[57] B. Astor,et al. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans , 2012, Kidney international.
[58] Sam K. Y. Sim,et al. Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults. , 2011, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[59] Benjamin J. Keller,et al. A Model for FRMD3 in Diabetic Nephropathy , 2013 .
[60] G. Pandini,et al. Insulin has multiple antiamyloidogenic effects on human neuronal cells. , 2013, Endocrinology.
[61] K. Skorecki,et al. Hypertension-misattributed kidney disease in African Americans. , 2013, Kidney international.
[62] A. Vinik,et al. Diabetic neuropathy. , 2013, Endocrinology and metabolism clinics of North America.
[63] M. Mishra,et al. Factor Nrf 2-Mediated Antioxidant Defense System in the Development of Diabetic Retinopathy , 2013 .
[64] Y. You,et al. Chronic Kidney Disease and Fibrosis Role of Nox 2 in diabetic kidney disease , 2013 .
[65] H. Yip,et al. Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease , 2013, Clinical and Experimental Nephrology.
[66] E. Barrett,et al. The endothelial cell: An “early responder” in the development of insulin resistance , 2013, Reviews in Endocrine and Metabolic Disorders.
[67] A. Leemans,et al. Microstructural White Matter Abnormalities and Cognitive Functioning in Type 2 Diabetes , 2012, Diabetes Care.
[68] E. Barrett,et al. Early Microvascular Recruitment Modulates Subsequent Insulin-Mediated Skeletal Muscle Glucose Metabolism During Lipid Infusion , 2012, Diabetes Care.
[69] S. Correia,et al. The impairment of insulin signaling in Alzheimer's disease , 2012, IUBMB life.
[70] B. Dormanesh,et al. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[71] A. Hofman,et al. Determinants of cerebellar and cerebral volume in the general elderly population , 2012, Neurobiology of Aging.
[72] J. Murabito,et al. Prevalence, Distribution, and Risk Factor Correlates of High Thoracic Periaortic Fat in the Framingham Heart Study , 2012, Journal of the American Heart Association.
[73] R. Akinyemi,et al. Does vascular pathology contribute to Alzheimer changes? , 2012, Journal of the Neurological Sciences.
[74] Y. Moon,et al. An Advanced Glycation End Product (AGE)-Receptor for AGEs (RAGE) Axis Restores Adipogenic Potential of Senescent Preadipocytes through Modulation of p53 Protein Function* , 2012, The Journal of Biological Chemistry.
[75] R. Bilous,et al. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[76] G. Biessels,et al. An update on type 2 diabetes, vascular dementia and Alzheimer's disease , 2012, Experimental Gerontology.
[77] E. Kanal. Gadolinium-based magnetic resonance contrast agents for neuroradiology: an overview. , 2012, Magnetic resonance imaging clinics of North America.
[78] H. Baelde,et al. Vegfa Protects the Glomerular Microvasculature in Diabetes , 2012, Diabetes.
[79] Allan L. Reiss,et al. White Matter Structural Differences in Young Children With Type 1 Diabetes: A Diffusion Tensor Imaging Study , 2012, Diabetes Care.
[80] Yao-min Hu,et al. A systematic review and meta-analysis of a-lipoic acid in the treatment of diabetic peripheral neuropathy , 2012 .
[81] S. Stone-Elander,et al. Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes , 2012, Nature.
[82] P. Toth,et al. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus , 2012, Cardiovascular Diabetology.
[83] M. Loitfelder,et al. Cerebral microbleeds: a review. , 2012, Panminerva medica.
[84] R. Gabbay,et al. Comparison of retinal vasodilator and constrictor responses in type 2 diabetes , 2012, Acta ophthalmologica.
[85] Benjamin J. Keller,et al. New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes , 2012, PLoS genetics.
[86] E. Newman,et al. Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease , 2012, Progress in Retinal and Eye Research.
[87] Sookja K. Chung,et al. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy. , 2012, Investigative ophthalmology & visual science.
[88] M. Shenton,et al. Resting-State Brain Functional Connectivity Is Altered in Type 2 Diabetes , 2012, Diabetes.
[89] R. Kahn,et al. Human brain changes across the life span: A review of 56 longitudinal magnetic resonance imaging studies , 2012, Human brain mapping.
[90] A. Convit,et al. Preliminary evidence for obesity and elevations in fasting insulin mediating associations between cortisol awakening response and hippocampal volumes and frontal atrophy , 2012, Psychoneuroendocrinology.
[91] Evan Fletcher,et al. Coevolution of white matter hyperintensities and cognition in the elderly , 2012, Neurology.
[92] D. Agalliu,et al. The role of pericytes in blood-brain barrier function and stroke. , 2012, Current pharmaceutical design.
[93] J. Hirschhorn,et al. Association Testing of Previously Reported Variants in a Large Case-Control Meta-analysis of Diabetic Nephropathy , 2012, Diabetes.
[94] A. Paterson,et al. Does Familial Clustering of Risk Factors for Long-Term Diabetic Complications Leave Any Place for Genes That Act independently? , 2012, Journal of Cardiovascular Translational Research.
[95] B. Frier,et al. Diabetes and cognitive dysfunction , 2012, The Lancet.
[96] S. Tafuro,et al. Adipose Tissue Overexpression of Vascular Endothelial Growth Factor Protects Against Diet-Induced Obesity and Insulin Resistance , 2012, Diabetes.
[97] K. Kalantar-Zadeh. A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death , 2012, Diabetes Care.
[98] B. Freedman. A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death , 2012, Diabetes Care.
[99] Ronald Klein,et al. Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy. , 2012, Archives of ophthalmology.
[100] L. Ferrucci,et al. Baseline Cardiovascular Risk Predicts Subsequent Changes in Resting Brain Function , 2012, Stroke.
[101] P. Liu,et al. Resistance to obesity by repression of VEGF gene expression through induction of brown-like adipocyte differentiation. , 2012, Endocrinology.
[102] D. Antonetti,et al. Protein Kinase Cβ Phosphorylates Occludin Regulating Tight Junction Trafficking in Vascular Endothelial Growth Factor–Induced Permeability In Vivo , 2012, Diabetes.
[103] K. Griendling,et al. Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System , 2012, Circulation research.
[104] C. Huang,et al. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta‐analysis of longitudinal studies , 2012, Internal medicine journal.
[105] Y. Reijmer,et al. Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetes. , 2012, Journal of diabetes and its complications.
[106] J. Skupień,et al. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease , 2012, Kidney international.
[107] S. Studenski,et al. Vitamin B12 and Neurological Function: Is There a Threshold Level? (P02.059) , 2012 .
[108] G. King,et al. Glomerular VEGF resistance induced by PKCδ/SHP‐1 activation and contribution to diabetic nephropathy , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[109] H. Verhaar,et al. association of chronic kidney disease with brain lesions on MRI or CT : systematic review , 2012 .
[110] P. Sirois,et al. Blockade of early and late retinal biochemical alterations associated with diabetes development by the selective bradykinin B1 receptor antagonist R-954 , 2012, Peptides.
[111] C. Langefeld,et al. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[112] E. Vaucher,et al. Ocular Application of the Kinin B1 Receptor Antagonist LF22-0542 Inhibits Retinal Inflammation and Oxidative Stress in Streptozotocin-Diabetic Rats , 2012, PloS one.
[113] L. Tao,et al. Glucagon-Like Peptide 1 Recruits Microvasculature and Increases Glucose Use in Muscle via a Nitric Oxide–Dependent Mechanism , 2012, Diabetes.
[114] R. DePinho,et al. FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. , 2012, Cell metabolism.
[115] Paula I. Moreira,et al. Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelation , 2012, Brain Research.
[116] L. Kappelle,et al. Diabetes, hyperglycaemia, and acute ischaemic stroke , 2012, The Lancet Neurology.
[117] Deyu Zhao,et al. Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects , 2012, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[118] Eric E. Smith,et al. Cerebral microinfarcts: the invisible lesions , 2012, The Lancet Neurology.
[119] K. Kalantar-Zadeh,et al. Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes , 2012, Diabetes.
[120] Samantha J. Brooks,et al. Impaired Insulin Sensitivity as Indexed by the HOMA Score Is Associated With Deficits in Verbal Fluency and Temporal Lobe Gray Matter Volume in the Elderly , 2012, Diabetes Care.
[121] E. Maltezos,et al. α-Lipoic Acid, Diabetic Neuropathy, and Nathan’s Prophecy , 2012, Angiology.
[122] M. Triggiani,et al. Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group , 2012, Allergy.
[123] Avi Ma'ayan,et al. Systems approach identifies HIPK2 as a critical regulator of kidney fibrosis , 2012, Nature Medicine.
[124] Jung-Lung Hsu,et al. Microstructural white matter abnormalities in type 2 diabetes mellitus: A diffusion tensor imaging study , 2012, NeuroImage.
[125] M. Szklo,et al. Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study , 2012, Neurology.
[126] D. Poulikakos,et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo , 2012, Nature Communications.
[127] J. Wang,et al. ER Stress and Apoptosis: A New Mechanism for Retinal Cell Death , 2011, Experimental diabetes research.
[128] Usrds. NIH, U. . Renal Data System: Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. , 2012 .
[129] W. Cefalu. A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: AM atter of Life or Death Time to dispense with the hemoglobin A1C in end-stage kidney , 2012 .
[130] Ning Wang,et al. Treatment effects of captopril on non-proliferative diabetic retinopathy. , 2012, Chinese medical journal.
[131] F. Ismail-Beigi,et al. Clinical implications of the ACCORD trial. , 2012, The Journal of clinical endocrinology and metabolism.
[132] T. Han,et al. A systematic review and meta-analysis of alpha-lipoic acid in the treatment of diabetic peripheral neuropathy , 2012 .
[133] Peter Riederer,et al. Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways , 2012, Journal of Neural Transmission.
[134] E. Uzar,et al. Serum prolidase activity and oxidative status in patients with diabetic neuropathy , 2012, Neurological Sciences.
[135] B. Kovatchev,et al. Muscle microvascular recruitment predicts insulin sensitivity in middle-aged patients with type 1 diabetes mellitus , 2012, Diabetologia.
[136] Mark E Molitch,et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. , 2011, The New England journal of medicine.
[137] M. White,et al. Inhibition of Insulin Signaling in Endothelial Cells by Protein Kinase C-induced Phosphorylation of p85 Subunit of Phosphatidylinositol 3-Kinase (PI3K)* , 2011, The Journal of Biological Chemistry.
[138] T. Kern,et al. Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia , 2011, Molecular vision.
[139] Lippincott Williams Wilkins,et al. Vitamin B12, cognition, and brain MRI measures: A cross-sectional examination , 2011, Neurology.
[140] B. Zlokovic,et al. Central nervous system pericytes in health and disease , 2011, Nature Neuroscience.
[141] J. Bülow,et al. The dynamics of the microcirculation in the subcutaneous adipose tissue is impaired in the postprandial state in type 2 diabetes , 2011, Clinical physiology and functional imaging.
[142] A. Ashley-Koch,et al. MYH9 and APOL1 are both associated with sickle cell disease nephropathy , 2011, British journal of haematology.
[143] A. Reiss,et al. Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease , 2011, Neurobiology of Aging.
[144] V. Bautch,et al. Stem cells and the vasculature , 2011, Nature Medicine.
[145] R. Kowluru,et al. Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease? , 2011, Investigative ophthalmology & visual science.
[146] Christos Davatzikos,et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy , 2011, The Lancet Neurology.
[147] Giulio Genovese,et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.
[148] P. Westermark,et al. Localized amyloids important in diseases outside the brain – lessons from the islets of Langerhans and the thoracic aorta , 2011, The FEBS journal.
[149] C. DeCarli,et al. Vitamin B12, cognition, and brain MRI measures , 2011, Neurology.
[150] E. Barrett,et al. Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature. , 2011, American journal of physiology. Endocrinology and metabolism.
[151] H. Hammes,et al. Alpha-Lipoic Acid for the Prevention of Diabetic Macular Edema , 2011, Ophthalmologica.
[152] R. Freeman,et al. Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy , 2011, Diabetes Care.
[153] B. Zinman,et al. Benefits of Renin-Angiotensin Blockade on Retinopathy in Type 1 Diabetes Vary With Glycemic Control , 2011, Diabetes Care.
[154] Sudha Seshadri,et al. Association of Metabolic Dysregulation With Volumetric Brain Magnetic Resonance Imaging and Cognitive Markers of Subclinical Brain Aging in Middle-Aged Adults , 2011, Diabetes Care.
[155] J. L. Wilkinson‐Berka,et al. Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat , 2011, Diabetologia.
[156] A. Vinik,et al. Neuropathy in prediabetes: does the clock start ticking early? , 2011, Nature Reviews Endocrinology.
[157] K. Clément,et al. Increased Adipose Tissue Oxygen Tension in Obese Compared With Lean Men Is Accompanied by Insulin Resistance, Impaired Adipose Tissue Capillarization, and Inflammation , 2011, Circulation.
[158] M. Sporn,et al. Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury. , 2011, Free radical biology & medicine.
[159] M. Brundel,et al. Cerebral microinfarcts: A systematic review of neuropathological studies , 2011, Alzheimer's & Dementia.
[160] Patrick J Heagerty,et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. , 2011, JAMA.
[161] E. Barrett,et al. Salsalate Attenuates Free Fatty Acid–Induced Microvascular and Metabolic Insulin Resistance in Humans , 2011, Diabetes Care.
[162] T. Dalkara,et al. Brain microvascular pericytes in health and disease , 2011, Acta Neuropathologica.
[163] M. Landray,et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial , 2011, The Lancet.
[164] R. Morishita,et al. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function. , 2011, Molecular bioSystems.
[165] A. Vinik,et al. Autonomic imbalance: prophet of doom or scope for hope? , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[166] T. Ahluwalia,et al. Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes , 2011, Diabetologia.
[167] Catherine Egan,et al. SDOCT Imaging to Identify Macular Pathology in Patients Diagnosed with Diabetic Maculopathy by a Digital Photographic Retinal Screening Programme , 2011, PloS one.
[168] C. DeCarli,et al. Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS). , 2011, Atherosclerosis.
[169] A. Vinik,et al. Quality of Life and Objective Measures of Diabetic Neuropathy in a Prospective Placebo-Controlled Trial of Ruboxistaurin and Topiramate , 2011, Journal of diabetes science and technology.
[170] D. Kolte,et al. Biochemical characterization of a novel high‐affinity and specific plasma kallikrein inhibitor , 2011, British journal of pharmacology.
[171] A. Clermont,et al. Plasma Kallikrein Mediates Retinal Vascular Dysfunction and Induces Retinal Thickening in Diabetic Rats , 2011, Diabetes.
[172] Jennifer K. Sun,et al. Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration , 2011, Diabetes Care.
[173] B. Zinman,et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. , 2011, Archives of internal medicine.
[174] T. Kodama,et al. Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. , 2011, Cell metabolism.
[175] A. Hofman,et al. Incidence of Cerebral Microbleeds in the General Population: The Rotterdam Scan Study , 2011, Stroke.
[176] Jasmin Divers,et al. A genome-wide association study for diabetic nephropathy genes in African Americans. , 2011, Kidney international.
[177] G. R. Jackson,et al. An integrated approach to diabetic retinopathy research. , 2011, Archives of ophthalmology.
[178] M. Rocco,et al. Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants. , 2011, Human pathology.
[179] M. Strachan. R D Lawrence Lecture 2010 ^ . The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[180] E. Barrett,et al. Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans. , 2011, The Journal of clinical endocrinology and metabolism.
[181] Riccardo E. Marioni,et al. Cognitive function, dementia and type 2 diabetes mellitus in the elderly , 2011, Nature Reviews Endocrinology.
[182] P. Carmeliet,et al. Neuronal FLT1 receptor and its selective ligand VEGF‐B protect against retrograde degeneration of sensory neurons , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[183] D. Wasserman,et al. The physiological regulation of glucose flux into muscle in vivo , 2011, Journal of Experimental Biology.
[184] S. Minoshima,et al. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. , 2011, Archives of neurology.
[185] C. Sapienza,et al. DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy , 2011, Epigenetics.
[186] T. Skalak,et al. Hemodynamic Systems Analysis of Capillary Network Remodeling During the Progression of Type 2 Diabetes , 2011, Microcirculation.
[187] R. Minshall,et al. A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase , 2009, Journal of cellular and molecular medicine.
[188] S. Antonio. Genomewide Linkage Scan for Diabetic Renal Failure and Albuminuria: The FIND Study , 2011 .
[189] H. Velázquez,et al. Podocyte vascular endothelial growth factor (Vegf164) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes , 2011, Diabetologia.
[190] Jeroen de Bresser,et al. Cerebral cortical thickness in patients with type 2 diabetes , 2010, Journal of the Neurological Sciences.
[191] V. Gudnason,et al. Cerebral microbleeds, retinopathy, and dementia , 2010, Neurology.
[192] O. Dekkers,et al. Genetic associations in diabetic nephropathy: a meta-analysis , 2010, Diabetologia.
[193] R. Hanson,et al. ELMO1 variants and susceptibility to diabetic nephropathy in American Indians. , 2010, Molecular genetics and metabolism.
[194] B. Freedman,et al. Lipotoxicity in diabetic nephropathy: the potential role of fatty acid oxidation. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[195] C. Langefeld,et al. The acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with nephropathy in Chinese patients with type 2 diabetes. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[196] Owen Carmichael,et al. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. , 2010, Archives of neurology.
[197] J. Coombes,et al. Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial. , 2010, Atherosclerosis.
[198] Ferdinando Giacco,et al. Oxidative stress and diabetic complications. , 2010, Circulation research.
[199] C. Forsblom,et al. Genetic Polymorphisms in Nitric Oxide Synthase 3 Gene and Implications for Kidney Disease: A Meta-Analysis , 2010, American Journal of Nephrology.
[200] C. Kahn,et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. , 2010, Cell metabolism.
[201] Rayaz A. Malik,et al. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.
[202] Aad van der Lugt,et al. Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study , 2010, Stroke.
[203] Bryan Maloney,et al. Beyond the signaling effect role of amyloid-β42 on the processing of APP, and its clinical implications , 2010, Experimental Neurology.
[204] L. Ferrucci,et al. Does accumulation of advanced glycation end products contribute to the aging phenotype? , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.
[205] C. Winkler,et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. , 2010, Journal of the American Society of Nephrology : JASN.
[206] A. Dale,et al. Life-span changes of the human brain white matter: diffusion tensor imaging (DTI) and volumetry. , 2010, Cerebral cortex.
[207] Xilin Yang,et al. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes. , 2010, JAMA.
[208] C. Winkler,et al. Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.
[209] Ann L. Albright,et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. , 2010, JAMA.
[210] Rodica Pop-Busui,et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial , 2010, The Lancet.
[211] R. Klein,et al. Are Individuals With Diabetes Seeing Better? , 2010, Diabetes.
[212] C. Enzinger,et al. The Impact of Sex and Vascular Risk Factors on Brain Tissue Changes with Aging: Magnetization Transfer Imaging Results of the Austrian Stroke Prevention Study , 2010, American Journal of Neuroradiology.
[213] R. G. Miller,et al. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study , 2010, Diabetologia.
[214] Walter T Ambrosius,et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. , 2010, The New England journal of medicine.
[215] S. Chung,et al. More severe type 2 diabetes‐associated ischemic stroke injury is alleviated in aldose reductase‐deficient mice , 2010, Journal of neuroscience research.
[216] J. Valls-Solé,et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe‐deration of Neurological Societies and the Peripheral Nerve Society , 2010, European journal of neurology.
[217] A. Vinik,et al. Neuropathy: The Crystal Ball for Cardiovascular Disease? , 2010, Diabetes Care.
[218] S. Rosset,et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene , 2010, Human Genetics.
[219] C. Fox,et al. Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. , 2010, Atherosclerosis.
[220] Lloyd Paul Aiello,et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema , 2010, Ophthalmology.
[221] R. Ramasamy,et al. Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. , 2010, Biochemical pharmacology.
[222] Robia G. Pautler,et al. Mitochondrial Superoxide Contributes to Blood Flow and Axonal Transport Deficits in the Tg2576 Mouse Model of Alzheimer's Disease , 2010, PloS one.
[223] J. Sahel,et al. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy. , 2010, Current opinion in investigational drugs.
[224] R. Klein,et al. Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. , 2010, American journal of ophthalmology.
[225] S. Garg,et al. Complications of intravitreal injections , 2010, Current opinion in ophthalmology.
[226] A. Yoshida,et al. Acute hyperglycemia-induced endothelial dysfunction in retinal arterioles in cats. , 2010, Investigative ophthalmology & visual science.
[227] G. King,et al. Activation of protein kinase C isoforms and its impact on diabetic complications. , 2010, Circulation research.
[228] M. Grant,et al. Erratum: The promise of cell-based therapies for diabetic complications: Challenges and solutions (Circulation Research (2010) 106 (854-869) , 2010 .
[229] R. Skidgel,et al. Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors , 2010, Neuropeptides.
[230] N. Powe,et al. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[231] F. Dekker,et al. Association Between CNDP1 Genotype and Diabetic Nephropathy Is Sex Specific , 2010, Diabetes.
[232] Z. Ni,et al. Prevalence of non-diabetic renal disease in patients with type 2 diabetes. , 2010, Diabetes research and clinical practice.
[233] S. Li Calzi,et al. Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits , 2010, EPMA Journal.
[234] A. Kazlauskas,et al. Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy. , 2010, Experimental eye research.
[235] Karen J. Ferguson,et al. Enlarged Perivascular Spaces on MRI Are a Feature of Cerebral Small Vessel Disease , 2010, Stroke.
[236] J. Albers,et al. Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study , 2010, Diabetes Care.
[237] Jianguo Zhang,et al. Albumin overload induces apoptosis in renal tubular epithelial cells through a CHOP-dependent pathway. , 2010, Omics : a journal of integrative biology.
[238] T. Hansen,et al. A Single Nucleotide Polymorphism within the Acetyl-Coenzyme A Carboxylase Beta Gene Is Associated with Proteinuria in Patients with Type 2 Diabetes , 2010, PLoS genetics.
[239] N. Durany,et al. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus , 2010, Neurobiology of Disease.
[240] S. Woods,et al. Peptide Designed to Elicit Apoptosis in Adipose Tissue Endothelium Reduces Food Intake and Body Weight , 2010, Diabetes.
[241] Activated protein C protects against diabetic nephropathy , 2010 .
[242] H. Hara,et al. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt. , 2010, Experimental eye research.
[243] A. Attie,et al. Secretion and Peripheral Insulin Action The Role of Blood Vessels, Endothelial Cells, and Vascular Pericytes in Insulin , 2010 .
[244] G. Siuzdak,et al. Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen‐induced retinopathy , 2010, Glia.
[245] E. Świętochowska,et al. Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy , 2010, Clinical and Experimental Medicine.
[246] M. Boulton,et al. Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock , 2009, The Journal of experimental medicine.
[247] L. Messina,et al. Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells. , 2009, Journal of vascular surgery.
[248] Yi Li,et al. Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies , 2009, Journal of clinical neurology.
[249] L. Aiello,et al. Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy , 2009, Nature Medicine.
[250] Angelo J. Canty,et al. A Genome-Wide Association Study Identifies a Novel Major Locus for Glycemic Control in Type 1 Diabetes, as Measured by Both A1C and Glucose , 2009, Diabetes.
[251] C. Grillo,et al. Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent , 2009, Brain Research.
[252] M. Woodward,et al. Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. , 2009, Archives of internal medicine.
[253] Blair H. Smith,et al. Assessment of neuropathic pain in primary care. , 2009, The American journal of medicine.
[254] E. Barrett,et al. The trafficking/interaction of eNOS and caveolin-1 induced by insulin modulates endothelial nitric oxide production. , 2009, Molecular endocrinology.
[255] C. Langefeld,et al. Genetic analysis of diabetic nephropathy on chromosome 18 in African Americans: linkage analysis and dense SNP mapping , 2009, Human Genetics.
[256] E. Barrett,et al. Muscle Contraction, but Not Insulin, Increases Microvascular Blood Volume in the Presence of Free Fatty Acid–Induced Insulin Resistance , 2009, Diabetes.
[257] Stephen S. Rich,et al. Confirmation of Genetic Associations at ELMO1 in the GoKinD Collection Supports Its Role as a Susceptibility Gene in Diabetic Nephropathy , 2009, Diabetes.
[258] M. Saito,et al. Role of cyclooxygenase in vasodilation of retinal blood vessels induced by bradykinin in Brown Norway rats. , 2009, Vascular pharmacology.
[259] A. Toga,et al. Brain Structure and Obesity , 2009, NeuroImage.
[260] J. Albers,et al. Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) , 2009, Circulation.
[261] E. Barrett,et al. Obesity Blunts Microvascular Recruitment in Human Forearm Muscle After a Mixed Meal , 2009, Diabetes Care.
[262] A. Krolewski,et al. Early nephropathy in type 1 diabetes: the importance of early renal function decline , 2009, Current opinion in nephrology and hypertension.
[263] Merlin C. Thomas,et al. The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes , 2009, Diabetes.
[264] Donald W. Bowden,et al. The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans , 2009, Human Genetics.
[265] J. Ochoa,et al. NEUROPATHIC PAIN: REDEFINITION AND A GRADING SYSTEM FOR CLINICAL AND RESEARCH PURPOSES , 2009, Neurology.
[266] Yongmei Liu,et al. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. , 2009, Kidney international.
[267] Hong Wang,et al. The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action , 2009, Diabetologia.
[268] C. Langefeld,et al. Variants in Intron 13 of the ELMO1 Gene are Associated with Diabetic Nephropathy in African Americans , 2009, Annals of human genetics.
[269] Judy E. Kim,et al. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. , 2009, Archives of ophthalmology.
[270] Suzanne Craft,et al. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. , 2009, Archives of neurology.
[271] J. Rood,et al. Reduced Adipose Tissue Oxygenation in Human Obesity , 2009, Diabetes.
[272] Stephen S. Rich,et al. Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes , 2009, Diabetes.
[273] J. Weinberg,et al. Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes , 2009, Diabetes Care.
[274] Steven Warach,et al. Cerebral Microbleeds : A Field Guide to their Detection and Interpretation , 2012 .
[275] T. Suuronen,et al. Inflammation in Alzheimer's disease: Amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors , 2009, Progress in Neurobiology.
[276] S. Bursell,et al. Plasma Kallikrein Mediates Angiotensin II Type 1 Receptor–Stimulated Retinal Vascular Permeability , 2009, Hypertension.
[277] B. Grinnell,et al. Distinct functions of activated protein C differentially attenuate acute kidney injury. , 2009, Journal of the American Society of Nephrology : JASN.
[278] Grant D. Huang,et al. Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.
[279] Sarah Aldred,et al. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. , 2008, Journal of Alzheimer's disease : JAD.
[280] R. King,et al. Epineurial microvasculitis in proximal diabetic neuropathy , 1998, Journal of Neurology.
[281] Z. Milicevic,et al. Anti-ganglioside GM1 antibody and distal symmetric “diabetic polyneuropathy” with dominant motor features , 1997, Diabetologia.
[282] J. Luchsinger,et al. Adiposity, type 2 diabetes, and Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.
[283] J. Tamsma,et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.
[284] W. Elliott. Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease , 2009 .
[285] R. Garrick. Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2009 .
[286] Ge Li,et al. Neuropathology in the adult changes in thought study: a review. , 2009, Journal of Alzheimer's disease : JAD.
[287] R. Klein,et al. The Role of Genetics in Susceptibility to Diabetic Retinopathy , 2009, International ophthalmology clinics.
[288] G. Perry,et al. Involvement of maillard reactions in Alzheimer disease , 2009, Neurotoxicity Research.
[289] F. Ziyadeh,et al. Vascular endothelial growth factor and diabetic nephropathy , 2008, Current diabetes reports.
[290] B. Mueller,et al. Diffusion Tensor Imaging Identifies Deficits in White Matter Microstructure in Subjects With Type 1 Diabetes That Correlate With Reduced Neurocognitive Function , 2008, Diabetes.
[291] A. Vinik,et al. German-Translated Norfolk Quality of Life (QOL-DN) Identifies the Same Factors as the English Version of the Tool and Discriminates Different Levels of Neuropathy Severity , 2008, Journal of diabetes science and technology.
[292] A. Smith,et al. Plasma vitamin B12 status and cerebral white-matter lesions , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[293] R. Klein,et al. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials , 2008, The Lancet.
[294] H. Parving,et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial , 2008, The Lancet.
[295] Rury R Holman,et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. , 2008, The New England journal of medicine.
[296] R. Holman,et al. 10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.
[297] T. Nyström,et al. The Potential Beneficial Role of Glucagon-like Peptide-1 in Endothelial Dysfunction and Heart Failure Associated with Insulin Resistance , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[298] K. Wanic,et al. Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes , 2008, Diabetes.
[299] Eric Vicaut,et al. Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus , 2008, Circulation.
[300] S. Yusuf,et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial , 2008, The Lancet.
[301] J. Abraham,et al. Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats , 2008, Metabolic Brain Disease.
[302] K. Yaffe,et al. Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2009 .
[303] S. Madsen-Bouterse,et al. Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives , 2008, Reviews in Endocrine and Metabolic Disorders.
[304] H. D. Vanguilder,et al. Diabetes downregulates presynaptic proteins and reduces basal synapsin I phosphorylation in rat retina , 2008, The European journal of neuroscience.
[305] R. Bache,et al. Regulation of coronary blood flow during exercise. , 2008, Physiological reviews.
[306] C. Fox,et al. Trends in Diabetes, High Cholesterol, and Hypertension in Chronic Kidney Disease Among U.S. Adults: 1988–1994 to 1999–2004 , 2008, Diabetes Care.
[307] Diederick Grobbee,et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.
[308] Vilmundur Gudnason,et al. Retinal and Cerebral Microvascular Signs and Diabetes , 2008, Diabetes.
[309] Allen R Kunselman,et al. Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. , 2008, Investigative ophthalmology & visual science.
[310] J. Hendrikse,et al. Cerebral perfusion in relation to cognitive function and type 2 diabetes , 2008, Diabetologia.
[311] J. Becker,et al. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study , 2008, Neurology.
[312] D. Ziegler. Painful diabetic neuropathy: treatment and future aspects , 2008, Diabetes/metabolism research and reviews.
[313] S. Talbot,et al. Retinal plasma extravasation in streptozotocin‐diabetic rats mediated by kinin B1 and B2 receptors , 2008, British journal of pharmacology.
[314] B. Freedman,et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. , 2008, Kidney international.
[315] Charles E. Riva,et al. Regulation of retinal blood flow in health and disease , 2008, Progress in Retinal and Eye Research.
[316] J. Dostrovsky,et al. Neuropathic pain , 2008, Neurology.
[317] K. Kamata,et al. Relationships among ET-1, PPARgamma, oxidative stress and endothelial dysfunction in diabetic animals. , 2008, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.
[318] M. V. Dinther,et al. Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis. , 2008, Kidney international.
[319] S. Kaushal,et al. Intravitreal steroids for macular edema: the past, the present, and the future. , 2008, Survey of ophthalmology.
[320] S. Weisberg,et al. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration , 2008, International Journal of Obesity.
[321] O. Lopez,et al. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[322] O. Pedersen,et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.
[323] M. Cooper,et al. Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product–Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-α–Dependent Pathway , 2008, Diabetes.
[324] H. Okamoto,et al. Angiotensin II-induced vasodilation via type 2 receptor: role of bradykinin and nitric oxide. , 2008, International immunopharmacology.
[325] R. Elston,et al. Genome-Wide Scan for Estimated Glomerular Filtration Rate in Multi-Ethnic Diabetic Populations , 2008, Diabetes.
[326] Olusola Ajilore,et al. Gray matter prefrontal changes in type 2 diabetes detected using MRI , 2008, Journal of magnetic resonance imaging : JMRI.
[327] H. Parving,et al. DIRECT Programme Study Group. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. , 2008 .
[328] R. Kunz,et al. Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the ReninAngiotensin System on Proteinuria in Renal Disease , 2008, Annals of Internal Medicine.
[329] A. Sadosky,et al. A Review of the Epidemiology of Painful Diabetic Peripheral Neuropathy, Postherpetic Neuralgia, and Less Commonly Studied Neuropathic Pain Conditions , 2008, Pain practice : the official journal of World Institute of Pain.
[330] M. Mintun,et al. Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve. , 2008, Archives of neurology.
[331] Filippo Crea,et al. Coronary microvascular dysfunction. , 2013, The New England journal of medicine.
[332] E. Barrett,et al. Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition. , 2007, American journal of physiology. Endocrinology and metabolism.
[333] P. Mitchell,et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial , 2007, The Lancet.
[334] D. Selkoe,et al. Soluble Aβ Inhibits Specific Signal Transduction Cascades Common to the Insulin Receptor Pathway* , 2007, Journal of Biological Chemistry.
[335] M. Esiri,et al. Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia , 2007, BMC neurology.
[336] Raghu Kalluri,et al. Structure and Function of Basement Membranes , 2007, Experimental biology and medicine.
[337] Jianping Ye,et al. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. , 2007, American journal of physiology. Endocrinology and metabolism.
[338] A. Algra,et al. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes , 2007, Diabetologia.
[339] E. Barrett,et al. Contraction Stimulates Nitric Oxide–Independent Microvascular Recruitment and Increases Muscle Insulin Uptake , 2007, Diabetes.
[340] S. Soltoff,et al. Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. , 2007, Trends in pharmacological sciences.
[341] Zhenqi Liu. Insulin at physiological concentrations increases microvascular perfusion in human myocardium. , 2007, American journal of physiology. Endocrinology and metabolism.
[342] J. Wardlaw,et al. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. , 2007, Brain : a journal of neurology.
[343] M. Artwohl,et al. Insulin does not regulate glucose transport and metabolism in human endothelium , 2007, European journal of clinical investigation.
[344] Jennifer K. Sun,et al. Clinical Factors Associated With Resistance to Microvascular Complications in Diabetic Patients of Extreme Disease Duration , 2007, Diabetes Care.
[345] L. Papa,et al. The VEGFR2 and PKA pathways converge at MEK/ERK1/2 to promote survival in serum deprived neuronal cells , 2007, Molecular and Cellular Biochemistry.
[346] C. Stehouwer,et al. Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome. , 2007, Hypertension.
[347] R. Colman,et al. Fifty years of research on the plasma kallikrein-kinin system: From protein structure and function to cell biology and in-vivo pathophysiology , 2007, Thrombosis and Haemostasis.
[348] R. Elston,et al. Genome-Wide Scans for Diabetic Nephropathy and Albuminuria in Multiethnic Populations , 2007, Diabetes.
[349] M. A. Viergever,et al. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus , 2007, Diabetologia.
[350] H. O. Neto,et al. Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy , 2007 .
[351] I. Liu,et al. Prevalence of Nondiabetic Renal Disease in Diabetic Patients , 2007, American Journal of Nephrology.
[352] B. Freedman,et al. Familial Clustering of Chronic Kidney Disease , 2007, Seminars in dialysis.
[353] D. Buerk,et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. , 2007, The Journal of clinical investigation.
[354] Marjana Tomic-Canic,et al. Cellular and molecular basis of wound healing in diabetes. , 2007, The Journal of clinical investigation.
[355] J. Weinberg,et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. , 2007, Journal of the American Society of Nephrology : JASN.
[356] H. Haller,et al. Deletion of Protein Kinase C-ε Signaling Pathway Induces Glomerulosclerosis and Tubulointerstitial Fibrosis In Vivo , 2007 .
[357] E. Boerwinkle,et al. A Genome-Wide Linkage Scan for Diabetic Retinopathy Susceptibility Genes in Mexican Americans With Type 2 Diabetes From Starr County, Texas , 2007, Diabetes.
[358] C. Langefeld,et al. A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[359] John V Pearson,et al. Identification of PVT1 as a Candidate Gene for End-Stage Renal Disease in Type 2 Diabetes Using a Pooling-Based Genome-Wide Single Nucleotide Polymorphism Association Study , 2007, Diabetes.
[360] P. Galuppo,et al. Endothelial Nitric Oxide Synthase Uncoupling Impairs Endothelial Progenitor Cell Mobilization and Function in Diabetes , 2007, Diabetes.
[361] M. Inaba,et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. , 2007, Journal of the American Society of Nephrology : JASN.
[362] F Fazekas,et al. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[363] A. Vinik,et al. Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.
[364] S. Calafato,et al. Oxidative stress and cellular stress response in diabetic nephropathy , 2007, Cell stress & chaperones.
[365] H. Haller,et al. Deletion of protein kinase C-epsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo. , 2007, Journal of the American Society of Nephrology : JASN.
[366] P. Scheltens,et al. Brain Lesions on MRI in Elderly Patients with Type 2 Diabetes Mellitus , 2006, European Neurology.
[367] Jonathan Stone,et al. Microvascular pathology in the aging human brain: Evidence that senile plaques are sites of microhaemorrhages , 2006, Neurobiology of Aging.
[368] G. King,et al. Reduction of Diabetes-Induced Oxidative Stress, Fibrotic Cytokine Expression, and Renal Dysfunction in Protein Kinase Cβ–Null Mice , 2006, Diabetes.
[369] Geert Jan Biessels,et al. Brain Imaging in Patients With Diabetes , 2006, Diabetes Care.
[370] U. Munzel,et al. Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy , 2006, Diabetes Care.
[371] J. Pacella,et al. Effect of Coronary Stenosis on Adjacent Bed Flow Reserve: Assessment of Microvascular Mechanisms Using Myocardial Contrast Echocardiography , 2006, Circulation.
[372] K. Chow,et al. Risk factors of vitamin B(12) deficiency in patients receiving metformin. , 2006, Archives of internal medicine.
[373] L. Aiello,et al. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy. , 2006, Ophthalmology.
[374] Jean-Luc Cracowski,et al. Methodological issues in the assessment of skin microvascular endothelial function in humans. , 2006, Trends in pharmacological sciences.
[375] S. Groeschel,et al. Virchow-Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature , 2006, Neuroradiology.
[376] R. Kawamori,et al. Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy , 2006, Diabetes Care.
[377] S. Chung,et al. Aldose Reductase–Deficient Mice Are Protected From Delayed Motor Nerve Conduction Velocity, Increased c-Jun NH2-Terminal Kinase Activation, Depletion of Reduced Glutathione, Increased Superoxide Accumulation, and DNA Damage , 2006, Diabetes.
[378] Jonathan R Lindner,et al. Mixed meal and light exercise each recruit muscle capillaries in healthy humans. , 2006, American journal of physiology. Endocrinology and metabolism.
[379] Ting Zhao,et al. Direct Effects of Glucagon-Like Peptide-1 on Myocardial Contractility and Glucose Uptake in Normal and Postischemic Isolated Rat Hearts , 2006, Journal of Pharmacology and Experimental Therapeutics.
[380] S. Sacco,et al. A population-based study of the incidence and prognosis of lacunar stroke , 2006, Neurology.
[381] A. Vinik,et al. Diabetic neuropathies: clinical manifestations and current treatment options , 2006, Nature Clinical Practice Endocrinology &Metabolism.
[382] E. Barrett,et al. Obesity Blunts Insulin-Mediated Microvascular Recruitment in Human Forearm Muscle , 2006, Diabetes.
[383] K. Isshiki,et al. Polymorphisms of the protein kinase C-beta gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria. , 2006, Diabetes care.
[384] Jeroen van der Grond,et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. , 2006, Diabetes.
[385] M. Brownlee,et al. Effect of R-(+)-α-lipoic acid on experimental diabetic retinopathy , 2006, Diabetologia.
[386] A. Goldfine,et al. Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. , 2006, Diabetes.
[387] F. Faraci. Reactive oxygen species: influence on cerebral vascular tone. , 2006, Journal of applied physiology.
[388] Simon Vogrin,et al. Cerebral cortex: An MRI-based study of volume and variance with age and sex , 2006, Journal of Clinical Neuroscience.
[389] R Nick Bryan,et al. Retinal Microvascular Abnormalities and MRI-Defined Subclinical Cerebral Infarction: The Atherosclerosis Risk in Communities Study , 2006, Stroke.
[390] M. Burnier,et al. Blockade of the renin–angiotensin–aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes , 2006, Journal of hypertension.
[391] K. Airaksinen,et al. Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery disease. , 2005, Diabetes.
[392] H. Hammes,et al. Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy. , 2006, Diabetologia.
[393] W. Burger,et al. Risk factors for the development of retinopathy in children and adolescents with Type 1 (insulin-dependent) diabetes mellitus , 2006, Diabetologia.
[394] Niels D Prins,et al. Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study. , 2006, Brain : a journal of neurology.
[395] A. Avogaro,et al. Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients. , 2006, Diabetes care.
[396] Ann Marie Schmidt,et al. Injury Advanced Glycation End Products : Sparking the Development of Diabetic Vascular , 2006 .
[397] R. Buchanan,et al. Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy. , 2006, Diabetes care.
[398] Thomas E. Lyons,et al. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot , 2005, The Lancet.
[399] H. Schmidt,et al. NADPH Oxidase Activity and Function Are Profoundly Greater in Cerebral Versus Systemic Arteries , 2005, Circulation research.
[400] J. Williamson,et al. Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies , 2005, Diabetologia.
[401] Karen L. Price,et al. Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy , 2005, Muscle & nerve.
[402] J. McGill,et al. The effect of ruboxistaurin on nephropathy in type 2 diabetes. , 2005, Diabetes care.
[403] T. Montine,et al. Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. , 2005, Archives of neurology.
[404] Steven Song,et al. The role of pericytes in blood-vessel formation and maintenance. , 2005, Neuro-oncology.
[405] B. Freedman,et al. Population-Based Screening for Family History of End-Stage Renal Disease among Incident Dialysis Patients , 2005, American Journal of Nephrology.
[406] A. Vinik,et al. Small fiber neuropathy is associated with the metabolic syndrome. , 2005, Metabolic syndrome and related disorders.
[407] Karen L. Price,et al. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. , 2005, Clinical therapeutics.
[408] J. Frisbee. Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[409] H. Hammes,et al. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. , 2005, Diabetes.
[410] A. Vinik,et al. Antibodies to neuronal structures: innocent bystanders or neurotoxins? , 2005, Diabetes care.
[411] M. Peakman,et al. Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy. , 2005, Diabetes care.
[412] W. März,et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.
[413] A. Avogaro,et al. Postprandial Myocardial Perfusion in Healthy Subjects and in Type 2 Diabetic Patients , 2005, Circulation.
[414] G. Chertow,et al. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. , 2005, Journal of the American Society of Nephrology : JASN.
[415] Yuan Zhang,et al. Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.
[416] A. Vinik,et al. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. , 2005, Diabetes technology & therapeutics.
[417] K. Jandeleit-Dahm,et al. Advanced Glycation End Products in Diabetes‐Associated Atherosclerosis and Renal Disease: Interventional Studies , 2005, Annals of the New York Academy of Sciences.
[418] W. Herman,et al. Underdiagnosis of peripheral neuropathy in type 2 diabetes. , 2005, Diabetes care.
[419] P. Matthews,et al. Risk factors for progression of brain atrophy in aging , 2005, Neurology.
[420] F. Nantel,et al. Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs. , 2005, European journal of pharmacology.
[421] F. Kim,et al. Free Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKKβ , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[422] K. Chia,et al. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects , 2005, Diabetologia.
[423] J. Jonas,et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. , 2005, Ophthalmology.
[424] A. Krolewski,et al. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. , 2005, Advances in chronic kidney disease.
[425] Dan Ziegler,et al. Diabetic neuropathies: a statement by the American Diabetes Association. , 2005, Diabetes care.
[426] Yusuke Nakamura,et al. Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. , 2005, Diabetes.
[427] P. Dyck,et al. Diabetic Neuropathies: Classification, Clinical Features, and Pathophysiological Basis , 2005, The neurologist.
[428] W. Köpcke,et al. Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study). , 2005, International journal of clinical pharmacology and therapeutics.
[429] Maria Inês Schmidt,et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. , 2005, Diabetes care.
[430] G. Gronseth,et al. Distal symmetric polyneuropathy: A definition for clinical research , 2005, Neurology.
[431] F. Gries,et al. The natural course of peripheral and autonomic neural function during the first two years after diagnosis of type 1 diabetes , 1988, Klinische Wochenschrift.
[432] Grupa badawcza Pkc-Drs. The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy. Initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial , 2005 .
[433] J. S. Yudkin,et al. "Vasocrine" signalling from perivascular , 2005 .
[434] R. Elston,et al. The Family Investigation of Nephropathy and Diabetes (FIND): design and methods. , 2005, Journal of diabetes and its complications.
[435] Jeffrey A. Cohen,et al. Distal symmetrical polyneuropathy: a definition for clinical research. A report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. , 2005, Archives of physical medicine and rehabilitation.
[436] F. Kim,et al. Downloaded from http://atvb.ahajournals.org / by guest on February 23, 2013Free Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKK� , 2022 .
[437] K. Sharma,et al. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetes mellitus , 2004, Current diabetes reports.
[438] J. Manson,et al. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. , 2004, Diabetes.
[439] J. Wegiel,et al. Cells of monocyte/microglial lineage are involved in both microvessel amyloidosis and fibrillar plaque formation in APPsw tg mice , 2004, Brain Research.
[440] C. Langefeld,et al. A genome scan for diabetic nephropathy in African Americans. , 2004, Kidney international.
[441] F. Marceau,et al. Bradykinin receptor ligands: therapeutic perspectives , 2004, Nature Reviews Drug Discovery.
[442] J. Clària,et al. F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control. , 2004, Metabolism: clinical and experimental.
[443] N. Joan Abbott,et al. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology , 2004, Neurochemistry International.
[444] Rhoda Au,et al. Cerebral Microbleeds: Prevalence and Associations With Cardiovascular Risk Factors in the Framingham Study , 2004, Stroke.
[445] H. Haller,et al. Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. , 2004, Diabetes.
[446] A. Vinik,et al. Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. , 2004, Diabetes care.
[447] Thomas H Marwick,et al. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.
[448] A. Vinik,et al. Diabetic neuropathies. , 2004, The Medical clinics of North America.
[449] R. Klein,et al. Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. , 2004, Ophthalmology.
[450] A. Vinik,et al. Focal entrapment neuropathies in diabetes. , 2004, Diabetes care.
[451] J. Arezzo,et al. Diabetic somatic neuropathies. , 2004, Diabetes care.
[452] Wadih Arap,et al. Reversal of obesity by targeted ablation of adipose tissue , 2004, Nature Medicine.
[453] C. Stehouwer,et al. Impaired Microvascular Function in Obesity: Implications for Obesity-Associated Microangiopathy, Hypertension, and Insulin Resistance , 2004, Circulation.
[454] C. Iadecola. Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[455] C. Langefeld,et al. Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[456] P. Abraham,et al. Impaired pressure-induced vasodilation at the foot in young adults with type 1 diabetes. , 2004, Diabetes.
[457] O. Raitakari,et al. Insulin induced increase in coronary flow reserve is abolished by dexamethasone in young men with uncomplicated type 1 diabetes , 2004, Heart.
[458] B. Lévy,et al. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. , 2004, The American journal of pathology.
[459] Mark E. Williams,et al. Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy , 2004, American Journal of Nephrology.
[460] P. Low,et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[461] A. Krolewski,et al. Familial factors determine the development of diabetic nephropathy in patients with IDDM , 1996, Diabetologia.
[462] N. Harris,et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis) , 1996, Diabetologia.
[463] M. Hanefeld,et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid , 1995, Diabetologia.
[464] N. Harris,et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography , 1993, Diabetologia.
[465] P. Sönksen,et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population , 1993, Diabetologia.
[466] M. F. Saad,et al. Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus , 1990, Diabetologia.
[467] C. Kilo,et al. Pericyte degeneration and acellular capillaries are increased in the feet of human diabetic patients , 1985, Diabetologia.
[468] T. Dornan,et al. Low density lipoprotein cholesterol: An association with the severity of diabetic retinopathy , 1982, Diabetologia.
[469] C. Langefeld,et al. Pathogenesis and Treatment of Kidney Disease and Hypertension Heritability of GFR and Albuminuria in Caucasians With Type 2 Diabetes Mellitus , 2004 .
[470] F. Karpe,et al. Nitric oxide and beta-adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans. , 2004, Circulation.
[471] A. Rosenbloom,et al. Limited joint mobility and diabetic retinopathy demonstrated by fluorescein angiography , 2004, European Journal of Pediatrics.
[472] Frank J T Staal,et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. , 2004, Diabetes.
[473] F. Karpe,et al. Nitric Oxide and &bgr;-Adrenergic Stimulation Are Major Regulators of Preprandial and Postprandial Subcutaneous Adipose Tissue Blood Flow in Humans , 2003 .
[474] S. Yagihashi,et al. Differential influence of increased polyol pathway on protein kinase C expressions between endoneurial and epineurial tissues in diabetic mice , 2003, Journal of neurochemistry.
[475] L. Rossetti,et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.
[476] A. Vinik,et al. Nerve Growth Factor and Diabetic Neuropathy , 2003, Experimental diabesity research.
[477] R. Couture,et al. Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin‐diabetic rat , 2003, British journal of pharmacology.
[478] K. Tuttle,et al. A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[479] M. Cotter,et al. Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. , 2003, Life sciences.
[480] Alan W. Stitt,et al. The role of advanced glycation in the pathogenesis of diabetic retinopathy. , 2003, Experimental and molecular pathology.
[481] R. Babaei-Jadidi,et al. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. , 2003, Diabetes.
[482] A. Demaine,et al. Polymorphisms of the aldose reductase gene and susceptibility to diabetic microvascular complications. , 2003, Current medicinal chemistry.
[483] E. Barrett,et al. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. , 2003, American journal of physiology. Endocrinology and metabolism.
[484] L. Cantley,et al. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. , 2003, The Journal of clinical investigation.
[485] Andrzej S Krolewski,et al. Regression of microalbuminuria in type 1 diabetes. , 2003, The New England journal of medicine.
[486] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[487] Craig S. Wong,et al. Epidemic of diabetic and nondiabetic renal disease among the Zuni Indians: the Zuni Kidney Project. , 2003, Journal of the American Society of Nephrology : JASN.
[488] Winfried Brenner,et al. Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive Labeling , 2003, Circulation.
[489] J. Haigh,et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. , 2003, The Journal of clinical investigation.
[490] G. King,et al. Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes. , 2003, Diabetes.
[491] P. O'Brien,et al. The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid , 2003 .
[492] A. Newton,et al. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. , 2003, The Biochemical journal.
[493] C. Sumner,et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance , 2003, Neurology.
[494] K. Yoshioka,et al. Aldose reductase gene polymorphism is associated with progression of diabetic nephropathy in Japanese patients with type 1 diabetes mellitus , 2003, Diabetes, obesity & metabolism.
[495] Karen J. Ferguson,et al. Willis on narcolepsy , 2003, Journal of neurology, neurosurgery, and psychiatry.
[496] I. Deary,et al. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. , 2003, Diabetes.
[497] Rury R Holman,et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). , 2003, Kidney international.
[498] A. Demaine,et al. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. , 2003, Journal of diabetes and its complications.
[499] P. O'Brien,et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. , 2003, Diabetes care.
[500] D. Brutsaert,et al. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. , 2003, Physiological reviews.
[501] H. Hammes,et al. Pericytes and the Pathogenesis of Diabetic Retinopathy , 2005, Diabetes.
[502] R. Hanson,et al. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. , 2002, Kidney international.
[503] S. Yusuf,et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. , 2002, Diabetes care.
[504] W. Markesbery,et al. Cerebrovascular Pathology and Dementia in Autopsied Honolulu‐Asia Aging Study Participants , 2002, Annals of the New York Academy of Sciences.
[505] J. Provenzale,et al. Tensor diffusion imaging in B12 leukoencephalopathy. , 2002, Journal of computer assisted tomography.
[506] A. Boulton,et al. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[507] P. Dandona. Endothelium, inflammation, and diabetes , 2002, Current diabetes reports.
[508] B. Lowell,et al. Adipose tissue mass can be regulated through the vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[509] S. Kaul,et al. Mechanism of Inducible Regional Dysfunction During Dipyridamole Stress , 2002, Circulation.
[510] O. Raitakari,et al. Obesity affects myocardial vasoreactivity and coronary flow response to insulin. , 2002, Obesity research.
[511] M. Cotter,et al. Effects of protein kinase Cβ inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism , 2002, Diabetes/metabolism research and reviews.
[512] F. Port,et al. Risk factors for proteinuria in a large, multiracial, southeast Asian population. , 2002, Journal of the American Society of Nephrology : JASN.
[513] T. Bek,et al. Bradykinin relaxation in small porcine retinal arterioles. , 2002, Investigative ophthalmology & visual science.
[514] T. Yoshikawa,et al. Intercellular adhesion molecule‐1 (ICAM‐1) polymorphism is associated with diabetic retinopathy in Type 2 diabetes mellitus , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[515] W. Bradley,et al. Demyelinating neuropathy in diabetes mellitus. , 2002, Archives of neurology.
[516] P. Iozzo,et al. Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans. , 2002, American journal of physiology. Endocrinology and metabolism.
[517] O. Raitakari,et al. The effects of insulin and short-term hyperglycaemia on myocardial blood flow in young men with uncomplicated Type I diabetes , 2002, Diabetologia.
[518] I. Komuro,et al. Endothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction , 2002, Circulation.
[519] A. Windebank,et al. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: New insights into pathophysiology and treatment , 2002, Muscle & nerve.
[520] O. Raitakari,et al. Dose-dependent vasodilating effects of insulin on adenosine-stimulated myocardial blood flow. , 2002, Diabetes.
[521] G. Slama,et al. eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[522] K. Donaghue,et al. Paraoxonase gene cluster is a genetic marker for early microvascular complications in Type 1 diabetes , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[523] B. Perkins,et al. Carpal tunnel syndrome in patients with diabetic polyneuropathy. , 2002, Diabetes care.
[524] R. de Caterina,et al. Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses , 2002, Circulation.
[525] C. Kim,et al. Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. , 2002, Diabetes.
[526] L. Aiello,et al. Characterization of protein kinase C β isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[527] A. Panduro,et al. The e4 allele of apolipoprotein E gene is a potential risk factor for the severity of macular edema in type 2 diabetic Mexican patients , 2002, Ophthalmic genetics.
[528] J. Eichberg. Protein kinase C changes in diabetes: is the concept relevant to neuropathy? , 2002, International review of neurobiology.
[529] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[530] S. Kaul,et al. Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. , 2001, Diabetes.
[531] S. Kaul,et al. Decrease in Coronary Blood Flow Reserve During Hyperlipidemia Is Secondary to an Increase in Blood Viscosity , 2001, Circulation.
[532] S. Tesfaye,et al. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy , 2001, Diabetologia.
[533] R. Kikkawa,et al. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. , 2001, Diabetes care.
[534] J. Goldstein,et al. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy , 2001, Muscle & nerve.
[535] M. Bromberg,et al. Painful sensory polyneuropathy associated with impaired glucose tolerance , 2001, Muscle & nerve.
[536] J. Tang,et al. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. , 2001, Diabetes.
[537] M. Bromberg,et al. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. , 2001, Diabetes care.
[538] R. Castellani,et al. Active glycation in neurofibrillary pathology of Alzheimer disease: Nε-(Carboxymethyl) lysine and hexitol-lysine , 2001 .
[539] S. Takasawa,et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. , 2001, The Journal of clinical investigation.
[540] J. Mužík,et al. Duration of Non-Insulin-Dependent Diabetes mellitus and the TNF-β NcoI Genotype as Predictive Factors in Proliferative Diabetic Retinopathy , 2001, Ophthalmologica.
[541] D. Alkon,et al. Role of insulin and insulin receptor in learning and memory , 2001, Molecular and Cellular Endocrinology.
[542] A. Nitenberg,et al. Impairment of coronary microvascular dilation in response to cold pressor--induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging. , 2001, Diabetes.
[543] I. Idris,et al. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes , 2001, Diabetologia.
[544] J. Concato,et al. Effect of Non–Insulin-Dependent Diabetes Mellitus on Myocardial Insulin Responsiveness in Patients With Ischemic Heart Disease , 2001, Circulation.
[545] T. Münzel,et al. Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus , 2001, Circulation research.
[546] A. Barden,et al. Advanced Glycation End Products: A Review , 2013 .
[547] A Hofman,et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.
[548] J M Wardlaw,et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study: the Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.
[549] M. Smith,et al. Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. , 2001, Free radical biology & medicine.
[550] T. Sano,et al. [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[551] K. Murthy,et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation , 2001, Nature Medicine.
[552] H. Utsumi,et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. , 2000, Diabetes.
[553] S. Woods,et al. Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. , 2000, Diabetes.
[554] Sookja K. Chung,et al. Aldose reductase-deficient mice are protected from reduction of nerve conduction associated with diabetes , 2000 .
[555] V. Mohan,et al. Familial clustering of diabetic retinopathy in type 2 diabetic patients , 2000 .
[556] M. Reljanović,et al. One Year Follow‐Up In Diabetic Patients After Surgical Treatment Of Carpal Tunnel Syndrome , 2000 .
[557] Ž. Metelko,et al. One year follow up in diabetic patients after surgical treatment of carpal tunnel syndrome , 2000 .
[558] T. Nishikawa,et al. The missing link: a single unifying mechanism for diabetic complications. , 2000, Kidney international. Supplement.
[559] K. Sharma,et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[560] R. Hanson,et al. Segregation analysis of diabetic nephropathy in Pima Indians. , 2000, Diabetes.
[561] Shao-Ling Zhang,et al. Molecular mechanism(s) of insulin action on the expression of the angiotensinogen gene in kidney proximal tubular cells , 2000, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[562] J. Knuuti,et al. Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men. , 2000, The Journal of clinical endocrinology and metabolism.
[563] T. Saruta,et al. Association between diabetic retinopathy and genetic variations in alpha2beta1 integrin, a platelet receptor for collagen. , 2000, Blood.
[564] T. Elhadd,et al. Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes. , 2000, Diabetes care.
[565] A. Zeiher,et al. Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[566] S. Rich,et al. Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. , 2000, Kidney international.
[567] T. Saruta,et al. Association between diabetic retinopathy and genetic variations in alpha2beta1 integrin, a platelet receptor for collagen. , 2000, Blood.
[568] H. Tritschler,et al. Effects of 3‐week oral treatment with the antioxidant thioctic acid (α‐lipoic acid) in symptomatic diabetic polyneuropathy , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[569] S. Kaul,et al. Role of capillaries in determining CBF reserve: new insights using myocardial contrast echocardiography. , 1999, The American journal of physiology.
[570] R. Klein,et al. Association of ocular disease and mortality in a diabetic population. , 1999, Archives of ophthalmology.
[571] N. Hotta,et al. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. , 1999, Diabetes.
[572] L. Groop,et al. Heritability of albumin excretion rate in families of patients with Type II diabetes , 1999, Diabetologia.
[573] T. Kigoshi,et al. Mitochondrial DNA mutations are associated with both decreased insulin secretion and advanced microvascular complications in Japanese diabetic subjects. , 1999, Journal of diabetes and its complications.
[574] A. Vinik. Diabetic neuropathy: pathogenesis and therapy. , 1999, The American journal of medicine.
[575] M. B. Brown,et al. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy , 1999, Neurology.
[576] J. Gross,et al. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. , 1999, Diabetes.
[577] Ambady Ramachandran,et al. Familial aggregation of diabetic kidney disease in Type 2 diabetes in south India. , 1999, Diabetes research and clinical practice.
[578] E. Barrett,et al. Acute vasoconstriction-induced insulin resistance in rat muscle in vivo. , 1999, Diabetes.
[579] J. Isner,et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. , 1999, The American journal of pathology.
[580] C. Baratti,et al. Effects of Posttraining Administration of Insulin on Retention of a Habituation Response in Mice: Participation of a Central Cholinergic Mechanism , 1999, Neurobiology of Learning and Memory.
[581] E. Friedman. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. , 1999, Diabetes care.
[582] E. Boyko,et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. , 1999, Diabetes care.
[583] P. Parfrey,et al. Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[584] N. B. Tütüncü,et al. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study. , 1998, Diabetes care.
[585] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[586] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[587] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[588] A. Schmidt,et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts , 1998, Nature Medicine.
[589] A R Jayaweera,et al. Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion? , 1998, Journal of the American College of Cardiology.
[590] P. Whelton,et al. Familial aggregation of renal disease in a population-based case-control study. , 1998, Journal of the American Society of Nephrology : JASN.
[591] F. Gries,et al. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[592] G. King,et al. Protein kinase C activation and the development of diabetic complications. , 1998, Diabetes.
[593] David G Armstrong,et al. Validation of a Diabetic Wound Classification System: The contribution of depth, infection, and ischemia to risk of amputation , 1998, Diabetes Care.
[594] R. Hanson,et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. , 1998, Diabetes.
[595] C. Whiteside,et al. Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. , 1998, Diabetes.
[596] T. Forst,et al. Skin microcirculation in patients with type I diabetes with and without neuropathy after neurovascular stimulation. , 1998, Clinical science.
[597] S. Kudoh,et al. Cell Type–Specific Angiotensin II–Evoked Signal Transduction Pathways , 1998 .
[598] A R Jayaweera,et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.
[599] J. Grande,et al. Redox regulation of renal DNA synthesis, transforming growth factor-beta1 and collagen gene expression. , 1998, Kidney international.
[600] T. Lehtimäki,et al. Coronary Flow Reserve Is Reduced in Young Men With IDDM , 1998, Diabetes.
[601] A. Sjølie,et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes , 1998, The Lancet.
[602] A. Veves,et al. The role of endothelial function on the foot. Microcirculation and wound healing in patients with diabetes. , 1998, Clinics in podiatric medicine and surgery.
[603] R. Danis,et al. Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531. , 1998, Investigative ophthalmology & visual science.
[604] L. Martens,et al. Costs and duration of care for lower extremity ulcers in patients with diabetes. , 1998, Clinical therapeutics.
[605] W. Banks,et al. Effect of Diabetes Mellitus on the Permeability of the Blood–Brain Barrier to Insulin , 1997, Peptides.
[606] S. Bursell,et al. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. , 1997, Investigative ophthalmology & visual science.
[607] M. Omata,et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. , 1997, Journal of the American College of Cardiology.
[608] A. Zacharias,et al. Autoimmune diabetic neuropathy. , 1997, Neurologic clinics.
[609] S. Kaul,et al. Recent advances in myocardial contrast echocardiography. , 1997, Current opinion in cardiology.
[610] Y Nishizuka,et al. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[611] E. Barrett,et al. Hemodynamic Actions of Insulin in Rat Skeletal Muscle: Evidence for Capillary Recruitment , 1997, Diabetes.
[612] R. Dietz,et al. High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. , 1997, Circulation research.
[613] P. Thomas,et al. Classification, Differential Diagnosis, and Staging of Diabetic Peripheral Neuropathy , 1997, Diabetes.
[614] W. Motz,et al. Impaired Coronary Flow Reserve in NIDDM: A Possible Role for Diabetic Cardiopathy in Humans , 1997, Diabetes.
[615] B R Johansson,et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.
[616] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.
[617] H. Hammes,et al. Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine , 1997, Diabetologia.
[618] S. Kaul,et al. Interactions between microbubbles and ultrasound: in vitro and in vivo observations. , 1997, Journal of the American College of Cardiology.
[619] C H Chang,et al. Use of dynamic capillaroscopy for studying cutaneous microcirculation in patients with diabetes mellitus. , 1997, Microvascular research.
[620] M. Ward,et al. Effects of rottlerin, an inhibitor of calmodulin-dependent protein kinase III, on cellular proliferation, viability, and cell cycle distribution in malignant glioma cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[621] A. Signorile,et al. Oxidative protein damage in human diabetic eye: evidence of a retinal participation , 1997, European journal of clinical investigation.
[622] K. Federlin,et al. A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[623] J. Samra,et al. Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. , 1996, Clinical science.
[624] 青木 琢也. 肺動脈血管内皮細胞における高濃度酸素暴露による intercellular adhesion molecule-1 (ICAM-1)発現と抗酸化機構との関連 , 1996 .
[625] H. Vlassara. Advanced glycation end-products and atherosclerosis. , 1996, Annals of medicine.
[626] S. Bursell,et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. , 1996, Science.
[627] M. Faul,et al. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta. , 1996, Journal of medicinal chemistry.
[628] R. Bucala,et al. Recent Progress in Advanced Glycation and Diabetic Vascular Disease: Role of Advanced Glycation End Product Receptors , 1996, Diabetes.
[629] A. Vinik,et al. The Natural Progression of Autonomic Neuropathy and Autonomic Function Tests in a Cohort of People With IDDM , 1996, Diabetes Care.
[630] S. Chokroverty,et al. Diabetic Amyotrophy: Current Concepts , 1996, Seminars in neurology.
[631] S. Bursell,et al. Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor , 1996, Science.
[632] C. Baratti,et al. Effects of Posttraining Administration of Glucose on Retention of a Habituation Response in Mice: Participation of a Central Cholinergic Mechanism , 1996, Neurobiology of Learning and Memory.
[633] E. Hirasaki,et al. Slowing of peripheral motor nerve conduction was ameliorated by aminoguanidine in streptozocin-induced diabetic rats. , 1996, European journal of endocrinology.
[634] R. Busse,et al. Molecular Responses of Endothelial Tissue to Kinins , 1996, Diabetes.
[635] P. Bennett,et al. Kidney Diseases in Diabetes , 1996 .
[636] T. Miyata,et al. Advanced glycation end-products in diabetic nephropathy. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[637] M. Hanefeld,et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). , 1995, Diabetologia.
[638] D. A. Krendel,et al. Successful treatment of neuropathies in patients with diabetes mellitus. , 1995, Archives of neurology.
[639] K. Kamata,et al. Decreased Ca2+ influx into the endothelium contributes to the decrease in endothelium-dependent relaxation in the aorta of streptozotocin-induced diabetic mice. , 1995, Research communications in molecular pathology and pharmacology.
[640] M. Edmonds. Diabetes: Clinical Science in Practice , 1995 .
[641] E Mervaala,et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.
[642] T. Batchelder,et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. , 1995, Archives of ophthalmology.
[643] K. Borch-Johnsen,et al. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. , 1995, Clinical science.
[644] B. Freedman,et al. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[645] D. Robbins,et al. Diabetes : clinical science in practice , 1995 .
[646] P. Corr,et al. Neural Dysfunction and Metabolic Imbalances in Diabetic Rats: Prevention by Acetyl-L-Carnitine , 1994, Diabetes.
[647] G S Kassab,et al. Morphometry of pig coronary venous system. , 1994, The American journal of physiology.
[648] H. Freyberger,et al. [Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent]. , 1994, Medizinische Klinik.
[649] M B Brown,et al. A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy , 1994, Diabetes Care.
[650] L. Kappos,et al. Gangliosides and autoimmune neuropathies: classification and clinical aspects of autoimmune neuropathies. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[651] A. Schmidt,et al. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[652] P. Cavanagh,et al. Assessment and management of foot disease in patients with diabetes. , 1994, The New England journal of medicine.
[653] G. King,et al. Characterization of the Mechanism for the Chronic Activation of Diacylglycerol-Protein Kinase C Pathway in Diabetes and Hypergalactosemia , 1994, Diabetes.
[654] N. Fineberg,et al. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. , 1994, The Journal of clinical investigation.
[655] E. Feldman,et al. The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. , 1994, The Journal of clinical investigation.
[656] S. Kagami,et al. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. , 1994, The Journal of clinical investigation.
[657] C. Lacroix,et al. Nerve biopsy findings in different patterns of proximal diabetic neuropathy , 1994, Annals of neurology.
[658] P. Björntorp,et al. Muscle Fiber Composition and Capillary Density in Women and Men With NIDDM , 1994, Diabetes Care.
[659] G. Ferrari,et al. α, βI, βII, δ, and ε Protein Kinase C Isoforms and Compound Activity in the Sciatic Nerve of Normal and Diabetic Rats , 1994 .
[660] G. Ferrari,et al. Alpha, beta I, beta II, delta, and epsilon protein kinase C isoforms and compound activity in the sciatic nerve of normal and diabetic rats. , 1994, Journal of neurochemistry.
[661] R. Klein,et al. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. , 1994, Archives of ophthalmology.
[662] R. Bucala,et al. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. , 1993, The American journal of pathology.
[663] W. Rathmann,et al. Mortality in Diabetic Patients with Cardiovascular Autonomic Neuropathy , 1993, Diabetic medicine : a journal of the British Diabetic Association.
[664] S. Bursell,et al. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. , 1993, The American journal of physiology.
[665] C Cobelli,et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. , 1993, The Journal of clinical investigation.
[666] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[667] A. Neil,et al. A Prospective Population-Based Study of Microalbuminuria as a Predictor of Mortality in NIDDM , 1993, Diabetes Care.
[668] A. Nitenberg,et al. Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic Patients With Angiographically Normal Coronary Arteries and Normal Left Ventricular Systolic Function , 1993, Diabetes.
[669] P. Watkins,et al. Progression of Diabetic Autonomic Neuropathy , 1993, Diabetic medicine : a journal of the British Diabetic Association.
[670] T. Lyons,et al. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. , 1993, The Journal of clinical investigation.
[671] W. J. Litchy,et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort , 1993, Neurology.
[672] M. Mcdaniel,et al. Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation , 1993, Diabetes.
[673] P. Scheltens,et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging , 1993, Journal of the Neurological Sciences.
[674] D. Dorsa,et al. Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus , 1993, Brain Research.
[675] D. Hewett‐Emmett,et al. Mortality of Mexican Americans With NIDDM: Retinopathy and other predictors in Starr County, Texas , 1993, Diabetes Care.
[676] L. Melton,et al. Erratum: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study (Neurology (1993) 43 (817-824)) , 1993 .
[677] Barbara E K Klein,et al. Epidemiology of Proliferative Diabetic Retinopathy , 1992, Diabetes Care.
[678] G. King,et al. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[679] M. Laakso,et al. Impaired Insulin-Mediated Skeletal Muscle Blood Flow in Patients With NIDDM , 1992, Diabetes.
[680] E. Tsilibary,et al. Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen. , 1992, The Journal of biological chemistry.
[681] H. Parving,et al. Is diabetic nephropathy an inherited complication? , 1992, Kidney international.
[682] S. Britland,et al. Acute and remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fibre pathology , 1992, Pain.
[683] M. Loeken,et al. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. , 1991, The Journal of biological chemistry.
[684] B. Agranoff,et al. Diminished Specific Activity of Cytosolic Protein Kinase C In Sciatic Nerve of Streptozocin-Induced Diabetic Rats and Its Correction by Dietary myo-Inositol , 1991, Diabetes.
[685] D. Troyer,et al. High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. , 1991, The American journal of physiology.
[686] L. Yannuzzi,et al. The effects of lipid lowering on diabetic retinopathy. , 1991, American journal of ophthalmology.
[687] M. Laakso,et al. Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. , 1991, The Journal of clinical endocrinology and metabolism.
[688] L. Melton,et al. The Rochester Diabetic Neuropathy Study , 1991, Neurology.
[689] J. Pickup,et al. Textbook of Diabetes , 1991 .
[690] R. Frank,et al. On the pathogenesis of diabetic retinopathy. A 1990 update. , 1991, Ophthalmology.
[691] J. V. van Swieten,et al. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. , 1991, Brain : a journal of neurology.
[692] D. Armstrong,et al. Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. , 1991, Free radical biology & medicine.
[693] Z. Katušić,et al. Superoxide anion and endothelial regulation of arterial tone. , 1991, Seminars in perinatology.
[694] E. Bouskela,et al. Nailfold capillaroscopy in non-insulin dependent diabetes mellitus: blood flow velocity during rest and post-occlusive reactive hyperaemia. , 1990, Clinical physiology.
[695] T. Takasu,et al. Characteristics of cranial nerve palsies in diabetic patients. , 1990, Diabetes research and clinical practice.
[696] C. Davidson,et al. Increase in Diacylglycerol Mass in Isolated Glomeruli by Glucose From De Novo Synthesis of Glycerolipids , 1990, Diabetes.
[697] M. Laakso,et al. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. , 1990, The Journal of clinical investigation.
[698] D. DeMets,et al. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? , 1989, Archives of internal medicine.
[699] R. Engerman,et al. Pathogenesis of Diabetic Retinopathy , 1989, Diabetes.
[700] E. Seaquist,et al. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.
[701] D L DeMets,et al. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. , 1988, JAMA.
[702] D. Mouton,et al. Prevalence of diabetic retinopathy and evaluation of risk factors. A review of 1,005 diabetic clinic patients. , 1988, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[703] C. Kilo,et al. Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy. , 1988, Diabetes/metabolism reviews.
[704] S. Woods,et al. Insulin in the brain. , 1987, Annual review of physiology.
[705] P. Marchetti,et al. Circulating lipid levels and severity of diabetic retinopathy in type I diabetes mellitus. , 1987, Ophthalmic research.
[706] M. Marcus,et al. Microvascular distribution of coronary vascular resistance in beating left ventricle. , 1986, The American journal of physiology.
[707] G. Bresnick. Diabetic retinopathy viewed as a neurosensory disorder. , 1986, Archives of ophthalmology.
[708] P. Dyck,et al. Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy , 1986, Annals of neurology.
[709] I. Herman,et al. Microvascular pericytes contain muscle and nonmuscle actins , 1985, The Journal of cell biology.
[710] J. Tooke,et al. Skin microvascular autoregulatory responses in type I diabetes: the influence of duration and control. , 1985, International journal of microcirculation, clinical and experimental.
[711] A. Cerami,et al. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. , 1984, Annals of internal medicine.
[712] D. DeMets,et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.
[713] R. E. Anderson,et al. Lipid peroxidation and retinal degeneration. , 1984, Current eye research.
[714] N. Maclaren,et al. Limited Joint Mobility in Childhood Diabetes: Family Studies , 1983, Diabetes Care.
[715] J. Miller,et al. Muscle Capillary Basement Membrane Width and Its Relationship to Diabetes Mellitus in Monozygotic Twins , 1983, Diabetes.
[716] G. Blankenship,et al. Vitrectomy for proliferative diabetic retinopathy associated with vitreous hemorrhage. , 1981, Ophthalmology.
[717] C. Kilo,et al. Pericyte Degeneration and Basement Membrane Thickening in Skeletal Muscle Capillaries of Human Diabetics , 1981, Diabetes.
[718] V. Fischer,et al. Capillary Basal Laminar Thickness in Diabetic Human Myocardium , 1979, Diabetes.
[719] M. Davis,et al. Prognosis for life in patients with diabetes: relation to severity of retinopathy. , 1979, Transactions of the American Ophthalmological Society.
[720] P. Hoffman,et al. Influence of Fixation and Morphometric Technics on Capillary Basement-membrane Thickening Prevalence Data in Diabetes , 1976, Diabetes.
[721] H. Parving,et al. Increased metabolic turnover rate and transcapillary escape rate of albumin in long-term juvenile diabetics. , 1975, Scandinavian journal of clinical and laboratory investigation.
[722] K. Lipscomb,et al. Effects of coronary stenoses on coronary flow reserve and resistance. , 1974, The American journal of cardiology.
[723] R. Unger,et al. Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. , 1968, The Journal of clinical investigation.
[724] P. Johnson,et al. Autoregulation of Blood Flow , 1963, Science.